StockMacro
Menu

Innospec

$75.56 -7.8% in 6 monthsMarket cap $1.9B

IOSP on XNAS, Materials, Innospec Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 7.2% to $473.6M in the latest quarter but the stock is down 24% in a month.

  • GoodRevenue up 4.7% over 12 months to $1.9B; profit $140.4M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

Industry
Chemicals & allied products (Materials)
Employees
2,450
Website
innospec.com
Listed
Nasdaq, US
Last results
3 Nov 2026
Next results
expected around 17 Feb 2027 (an estimate: a year ago it reported on 18 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $473.6M, net income $31.8M.
Quarter to 31 Dec 2021: revenue $413.2M, net income $23.9MQuarter to 31 Dec 2021: revenue $413.2M, net income $23.9MQuarter to 31 Mar 2022: revenue $472.4M, net income $36.5MQuarter to 31 Mar 2022: revenue $472.4M, net income $36.5MQuarter to 30 Jun 2022: revenue $467.6M, net income $32.3MQuarter to 30 Jun 2022: revenue $467.6M, net income $32.3MQuarter to 30 Sep 2022: revenue $513.0M, net income $38.7MQuarter to 30 Sep 2022: revenue $513.0M, net income $38.7MQuarter to 31 Dec 2022: revenue $510.7M, net income $25.5MQuarter to 31 Dec 2022: revenue $510.7M, net income $25.5MQuarter to 31 Mar 2023: revenue $509.6M, net income $33.2MQuarter to 31 Mar 2023: revenue $509.6M, net income $33.2MQuarter to 30 Jun 2023: revenue $480.4M, net income $28.9MQuarter to 30 Jun 2023: revenue $480.4M, net income $28.9MQuarter to 30 Sep 2023: revenue $464.1M, net income $39.2MQuarter to 30 Sep 2023: revenue $464.1M, net income $39.2MQuarter to 31 Dec 2023: revenue $494.7M, net income $37.8MQuarter to 31 Dec 2023: revenue $494.7M, net income $37.8MQuarter to 31 Mar 2024: revenue $500.2M, net income $41.4MQuarter to 31 Mar 2024: revenue $500.2M, net income $41.4MQuarter to 30 Jun 2024: revenue $435.0M, net income $31.2MQuarter to 30 Jun 2024: revenue $435.0M, net income $31.2MQuarter to 30 Sep 2024: revenue $443.4M, net income $33.4MQuarter to 30 Sep 2024: revenue $443.4M, net income $33.4MQuarter to 31 Dec 2024: revenue $466.8M, net income -$70.4MQuarter to 31 Dec 2024: revenue $466.8M, net income -$70.4MQuarter to 31 Mar 2025: revenue $440.8M, net income $32.8MQuarter to 31 Mar 2025: revenue $440.8M, net income $32.8MQuarter to 30 Jun 2025: revenue $439.7M, net income $23.5MQuarter to 30 Jun 2025: revenue $439.7M, net income $23.5MQuarter to 30 Sep 2025: revenue $441.9M, net income $12.9MQuarter to 30 Sep 2025: revenue $441.9M, net income $12.9MQuarter to 31 Dec 2025: revenue $455.6M, net income $47.4MQuarter to 31 Dec 2025: revenue $455.6M, net income $47.4MQuarter to 31 Mar 2026: revenue $453.2M, net income $30.4MQuarter to 31 Mar 2026: revenue $453.2M, net income $30.4MQuarter to 30 Jun 2026: revenue $491.4M, net income $30.8MQuarter to 30 Jun 2026: revenue $491.4M, net income $30.8MQuarter to 30 Sep 2026: revenue $473.6M, net income $31.8MQuarter to 30 Sep 2026: revenue $473.6M, net income $31.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $513.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$473.6M$31.8M
30 Jun 2026$491.4M$30.8M
31 Mar 2026$453.2M$30.4M
31 Dec 2025$455.6M$47.4M
30 Sep 2025$441.9M$12.9M
30 Jun 2025$439.7M$23.5M
31 Mar 2025$440.8M$32.8M
31 Dec 2024$466.8M-$70.4M
30 Sep 2024$443.4M$33.4M
30 Jun 2024$435.0M$31.2M
31 Mar 2024$500.2M$41.4M
31 Dec 2023$494.7M$37.8M
30 Sep 2023$464.1M$39.2M
30 Jun 2023$480.4M$28.9M
31 Mar 2023$509.6M$33.2M
31 Dec 2022$510.7M$25.5M
30 Sep 2022$513.0M$38.7M
30 Jun 2022$467.6M$32.3M
31 Mar 2022$472.4M$36.5M
31 Dec 2021$413.2M$23.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.9B $1.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +4.7% -0.3%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $140.4M -$1.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $5.67 -$0.03
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 27.7% 28.0% 22.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 8.8% 6.9% -2.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 7.5% -0.1% 1.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 10.5% 1.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – $54.8M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $251.9M $270.8M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$251.9M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.81
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $55.74
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 13.3 29.8
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.99 1.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.86 1.4
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.4 2.5
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 2.3% 2.0%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
InnospecIOSP (this company) $1.9B13.30.99+4.7%7.5%
IngevityNGVT $1.8B30.41.6-6.5%5.3%
OlinOLN $1.7Bloss0.26-0.7%-3.3%
ChemoursCC $1.6Bloss0.28+0.1%-2.6%
HuntsmanHUN $1.5Bloss0.26-4.7%-5.8%
EcovystECVT $977.5M27.11.0+45%3.7%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$27K

bought $27K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+5.1%

289 13F filers vs 275

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

99%

24.5M shares held by 13F filers (30 Sep 2026) of 24.6M outstanding (31 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

1.9%

456K shares sold short (30 Oct 2026) of 24.6M outstanding (31 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.9

456K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-5.5%

483K shares sold short in the report before, 456K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

58%

58% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 48%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+7.2%

$473.6M vs $441.9M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+10%

$15.8M vs $14.3M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

4

4 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4.0×

4 articles in the last 7 days; its usual week has 1.

Price $75.56 on 20 Nov 2026, +7.0% over 12 months (12-month range $65.89 to $101.41)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $547K in the last 12 months (the 12 months before: -$1.6M).
Revenue per quarter. Revenue $473.6M in the latest quarter, +7.2% on a year earlier.
Capital spending per quarter. Capital spending $15.8M in the latest quarter, +10% on a year earlier.
Institutional holders (13F filers). 289 13F filers reported holding it in the latest 13F quarter, +15% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
4 Jun 20268-K and other filingsDirector or officer change
4 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Oct 2025Sharp changeShort interest spike: short interest spike, 579K vs usual 300K (2025-10-15); 2.2x the same period a year earlier
15 May 2025Sharp changeMany funds opening a new position: many funds opening a new position, 40 vs usual 21.50 (2025-03-31); 1.6x the same period a year earlier
3 Apr 20248-K and other filingsDirector or officer change
3 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 May 20238-K and other filingsDirector or officer change
15 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 May 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 17.7M vs usual 9.4M (2023-03-31); 2.1x the same period a year earlier
10 Mar 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 233K)
14 Feb 2023Sharp changeMany funds opening a new position: many funds opening a new position, 36 vs usual 17 (2022-12-31); 2.2x the same period a year earlier
7 Dec 20218-K and other filingsDirector or officer change
7 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Feb 2022: -$37K published
Month from 1 Mar 2022: -$1.6M published
Month from 1 Dec 2022: $81K published
Month from 1 Feb 2023: -$992K published
Month from 1 Mar 2023: -$6.6M published
Month from 1 May 2023: -$23K published
Month from 1 Nov 2023: -$99K published
Month from 1 Feb 2024: -$4.8M published
Month from 1 Mar 2024: -$921K published
Month from 1 May 2024: -$43K published
Month from 1 Aug 2024: -$1.1M published
Month from 1 Nov 2024: -$163K published
Month from 1 Jan 2025: -$55K published
Month from 1 Feb 2025: -$1.1M published
Month from 1 Mar 2025: -$432K published
Month from 1 May 2025: -$40K published
Month from 1 Nov 2025: $25K published
Month from 1 Feb 2026: -$169K published
Month from 1 Mar 2026: -$406K published
Month from 1 Nov 2026: $27K published
Revenue per quarter
Quarter ended 31 Dec 2021: $413.2M, +33% on a year earlier; public on 17 Feb 2022
Quarter ended 31 Mar 2022: $472.4M, +39% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $467.6M, +32% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $513.0M, +36% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $510.7M, +24% on a year earlier; public on 23 Feb 2023
Quarter ended 31 Mar 2023: $509.6M, +7.9% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $480.4M, +2.7% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $464.1M, -9.5% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $494.7M, -3.1% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $500.2M, -1.8% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $435.0M, -9.5% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $443.4M, -4.5% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $466.8M, -5.6% on a year earlier; public on 20 Feb 2025
Quarter ended 31 Mar 2025: $440.8M, -12% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $439.7M, +1.1% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $441.9M, -0.3% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $455.6M, -2.4% on a year earlier; public on 19 Feb 2026
Quarter ended 31 Mar 2026: $453.2M, +2.8% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $491.4M, +12% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $473.6M, +7.2% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $11.7M, +46% on a year earlier; public on 17 Feb 2022
Quarter ended 31 Mar 2022: $8.4M, -18% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $9.0M, -2.2% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $9.7M, +23% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $12.5M, +6.8% on a year earlier; public on 23 Feb 2023
Quarter ended 31 Mar 2023: $17.7M, +111% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $14.9M, +66% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $12.6M, +30% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $16.9M, +35% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $10.7M, -40% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $10.9M, -27% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $7.7M, -39% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $12.1M, -28% on a year earlier; public on 20 Feb 2025
Quarter ended 31 Mar 2025: $8.4M, -21% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $13.0M, +19% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $14.3M, +86% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $14.6M, +21% on a year earlier; public on 19 Feb 2026
Quarter ended 31 Mar 2026: $8.9M, +6.0% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $17.7M, +36% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $15.8M, +10% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 163; public on 14 Feb 2022
31 Mar 2022 report: 175; public on 16 May 2022
30 Jun 2022 report: 184; public on 15 Aug 2022
30 Sep 2022 report: 177; public on 14 Nov 2022
31 Dec 2022 report: 208; public on 14 Feb 2023
31 Mar 2023 report: 209; public on 15 May 2023
30 Jun 2023 report: 189; public on 14 Aug 2023
30 Sep 2023 report: 194; public on 14 Nov 2023
31 Dec 2023 report: 215; public on 14 Feb 2024
31 Mar 2024 report: 227; public on 15 May 2024
30 Jun 2024 report: 252; public on 14 Aug 2024
30 Sep 2024 report: 250; public on 14 Nov 2024
31 Dec 2024 report: 256; public on 14 Feb 2025
31 Mar 2025 report: 261; public on 15 May 2025
30 Jun 2025 report: 250; public on 14 Aug 2025
30 Sep 2025 report: 251; public on 14 Nov 2025
31 Dec 2025 report: 249; public on 17 Feb 2026
31 Mar 2026 report: 259; public on 15 May 2026
30 Jun 2026 report: 275; public on 14 Aug 2026
30 Sep 2026 report: 289; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $27K (12 Nov 2026), higher than 92% of its own history.
  • Insider net buying (open market): Insiders sold a net $547K in the last 12 months (the 12 months before: -$1.6M).
  • Revenue per quarter: Revenue $473.6M in the latest quarter, +7.2% on a year earlier.
  • Capital spending per quarter: Capital spending $15.8M in the latest quarter, +10% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: no sales; 1 purchase, $27K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
12 Nov 2026Leslie J ParretteDirectorBuy345$79.69$27KForm 4
3 Mar 2026Claudia PocciaDirectorSell119$76.56$9KForm 4
3 Mar 2026Larry PadfieldDirectorSell594$76.56$45KForm 4
3 Mar 2026Ian CleminsonEVP & CFOSell2,380$76.56$182KForm 4
3 Mar 2026Milton C BlackmoreDirectorSell594$76.56$45KForm 4
3 Mar 2026David B. JonesSVP, GC & CCOSell1,028$75.64$78KForm 4
3 Mar 2026David LandlessDirectorSell594$76.56$45KForm 4
24 Feb 2026Larry PadfieldDirectorSellafter exercising options1,030$81.84$84KForm 4

289 institutions reported shares at the end of Q3 2026, 99% of the shares outstanding; 44 opened a position, 31 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.4.3M17.5%$411.9M-60K-1.4%
Vanguard Portfolio Management LLC1.9M7.63%$179.2M-4,051-0.2%
Dimensional Fund Advisors LP1.4M5.57%$130.8M+67K+5.1%
Allspring Global Investments Holdings, LLC1.2M4.72%$110.5M-731K-39%
Vanguard Capital Management LLC1.1M4.50%$105.7M+679+0.1%
State Street Corp1.0M4.19%$98.4M+36K+3.7%
Victory Capital Management Inc812K3.30%$77.4M+152K+23%
Nuveen, LLC793K3.22%$75.6M+37K+4.9%
Goldman Sachs Group Inc650K2.64%$62.0M-12K-1.8%
Geode Capital Management, LLC650K2.64%$62.0M-17K-2.5%

Company events

All 25 company events

In 12 months: 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Jun 2026Director or officer change8-K
21 May 2024Signed a major agreementSame filing: took on new debt8-K
3 Apr 2024Director or officer change8-K
1 Jun 2023Signed a major agreementSame filing: took on new debt8-K
15 May 2023Director or officer change8-K
7 Dec 2021Director or officer change8-K
25 Feb 2021Director or officer change8-K
6 Nov 2020Director or officer change8-K
Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

10 Mar 2023confirmed

Confirmed across sources Insiders and Institutional holdings

Innospec (IOSP): saw 36 13F filers open a new position in the quarter ended 31 Dec 2022, 2.2× the same quarter last year, while it had 3 insiders buy $233K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 23 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Feb 2023
  • Insiders: Clustered insider buying, became public on 10 Mar 2023
2020-12-31: 182021-03-31: 172021-06-30: 202021-09-30: 172021-12-31: 162022-03-31: 172022-06-30: 262022-09-30: 162022-12-31: 36
The quarter ended 31 Dec 2022 against the 8 quarters before it. this quarterearliernormal: 17
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 14 Feb 2023

Innospec saw 36 13F filers open a new position in the quarter ended 31 Dec 2022, 2.2× the same quarter last year.

This period
36 (the quarter ended 31 Dec 2022)
Normal quarter (median of 8 earlier)
17
Typical spread (median absolute deviation)
1
How far from its usual level
+6.3
Same quarter last year
16
History used
3,379 days
2020-12-31: 182021-03-31: 172021-06-30: 202021-09-30: 172021-12-31: 162022-03-31: 172022-06-30: 262022-09-30: 162022-12-31: 36
the quarter ended 31 Dec 20228 earlier quartersnormal: 17

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Insiders: Clustered insider buying became public on 10 Mar 2023

Innospec had 3 insiders buy $233K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$233K
Window
8 Feb 2023 to 10 Mar 2023

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 13 Nov 2026Insiders record

    PARRETTE LESLIE J (director) bought 345 shares of IOSP ($27,493) (dated 12 Nov 2026)

  2. 4 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 4 Jun 2026Filings record

    Director or officer change

  4. 18 Nov 2025Insiders record

    PARRETTE LESLIE J (director) bought 340 shares of IOSP ($25,191) (dated 17 Nov 2025)

  5. 25 Oct 2025Short interest and volume change

    had 579K shares sold short in the 15 Oct 2025 report, 2.2× the same report last year.

    Same report last year: 258K; its normal report is 300K.

    See the evidence
    This period
    579K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    300K
    Typical spread (median absolute deviation)
    41K
    How far from its usual level
    +4.6
    Same report last year
    258K
    History used
    2,847 days
    2024-10-15: 258K2024-10-31: 226K2024-11-15: 217K2024-11-29: 279K2024-12-13: 300K2024-12-31: 384K2025-01-15: 324K2025-01-31: 289K2025-02-14: 262K2025-02-28: 300K2025-03-14: 459K2025-03-31: 383K2025-04-15: 331K2025-04-30: 293K2025-05-15: 241K2025-05-30: 254K2025-06-13: 183K2025-06-30: 372K2025-07-15: 261K2025-07-31: 322K2025-08-15: 435K2025-08-29: 315K2025-09-15: 335K2025-09-30: 424K2025-10-15: 579K
    the 15 Oct 2025 report24 earlier reportsnormal: 300K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 15 May 2025Institutional holdings change

    saw 40 13F filers open a new position in the quarter ended 31 Mar 2025, 1.6× the same quarter last year.

    Same quarter last year: 25; its normal quarter is 21.5.

    See the evidence
    This period
    40 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    21.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +4.2
    Same quarter last year
    25
    History used
    4,200 days
    2023-03-31: 112023-06-30: 162023-09-30: 192023-12-31: 212024-03-31: 252024-06-30: 352024-09-30: 232024-12-31: 222025-03-31: 40
    the quarter ended 31 Mar 20258 earlier quartersnormal: 21.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  7. 15 Aug 2024Insiders record

    PARRETTE LESLIE J (director) bought 143 shares of IOSP ($15,135) (dated 14 Aug 2024)

  8. 21 May 2024Insiders record

    PARRETTE LESLIE J (director) bought 189 shares of IOSP ($24,867) (dated 20 May 2024)

  9. 3 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 3 Apr 2024Filings record

    Director or officer change

  11. 24 Feb 2024Insiders record

    PARRETTE LESLIE J (director) bought 410 shares of IOSP ($50,824) (dated 23 Feb 2024)

  12. 15 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 15 May 2023Filings record

    Director or officer change

  14. 12 May 2023Insiders record

    PARRETTE LESLIE J (director) bought 515 shares of IOSP ($49,826) (dated 11 May 2023)

  15. 9 May 2023Financials change

    spent $17.7M on capital projects in the quarter ended 31 Mar 2023, 2.1× the same quarter last year.

    Same quarter last year: $8.4M; its normal quarter is $9.4M.

    See the evidence
    This period
    $17.7M (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    $9.4M
    Typical spread (median absolute deviation)
    $950K
    How far from its usual level
    +5.9
    Same quarter last year
    $8.4M
    History used
    4,565 days
    2021-03-31: $10.3M2021-06-30: $9.2M2021-09-30: $7.9M2021-12-31: $11.7M2022-03-31: $8.4M2022-06-30: $9.0M2022-09-30: $9.7M2022-12-31: $12.5M2023-03-31: $17.7M
    the quarter ended 31 Mar 20238 earlier quartersnormal: $9.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  16. 21 Mar 2023Insiders record

    BARNES CORBIN (SVP, Corporate Dev and IR) bought 400 shares of IOSP ($39,900) (dated 20 Mar 2023)

  17. 10 Mar 2023several at once

    saw 36 13F filers open a new position in the quarter ended 31 Dec 2022, 2.2× the same quarter last year, while it had 3 insiders buy $233K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 23 days.

    See the evidence (2 changes)

    Institutional holdings: Many funds opening a new position became public on 14 Feb 2023

    Innospec saw 36 13F filers open a new position in the quarter ended 31 Dec 2022, 2.2× the same quarter last year.

    This period
    36 (the quarter ended 31 Dec 2022)
    Normal quarter (median of 8 earlier)
    17
    Typical spread (median absolute deviation)
    1
    How far from its usual level
    +6.3
    Same quarter last year
    16
    History used
    3,379 days
    2020-12-31: 182021-03-31: 172021-06-30: 202021-09-30: 172021-12-31: 162022-03-31: 172022-06-30: 262022-09-30: 162022-12-31: 36
    the quarter ended 31 Dec 20228 earlier quartersnormal: 17

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Insiders: Clustered insider buying became public on 10 Mar 2023

    Innospec had 3 insiders buy $233K of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $233K
    Window
    8 Feb 2023 to 10 Mar 2023

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  18. 10 Mar 2023Insiders change

    had 3 insiders buy $233K of its shares on the open market within 30 days (3 filings).

    Who bought: Jones David B., Parrette Leslie J, Barnes Corbin.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $233K
    Window
    8 Feb 2023 to 10 Mar 2023

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  19. 10 Mar 2023Insiders record

    BARNES CORBIN (SVP, Corporate Dev and IR) bought 1,250 shares of IOSP ($132,500) (dated 9 Mar 2023)

  20. 7 Mar 2023Insiders record

    PARRETTE LESLIE J (director) bought 450 shares of IOSP ($50,108) (dated 6 Mar 2023)

  21. 3 Mar 2023Insiders record

    Jones David B. (SVP, GC & CCO) bought 459 shares of IOSP ($50,022) (dated 2 Mar 2023)

  22. 14 Feb 2023Institutional holdings change

    saw 36 13F filers open a new position in the quarter ended 31 Dec 2022, 2.2× the same quarter last year.

    Same quarter last year: 16; its normal quarter is 17.

    See the evidence
    This period
    36 (the quarter ended 31 Dec 2022)
    Normal quarter (median of 8 earlier)
    17
    Typical spread (median absolute deviation)
    1
    How far from its usual level
    +6.3
    Same quarter last year
    16
    History used
    3,379 days
    2020-12-31: 182021-03-31: 172021-06-30: 202021-09-30: 172021-12-31: 162022-03-31: 172022-06-30: 262022-09-30: 162022-12-31: 36
    the quarter ended 31 Dec 20228 earlier quartersnormal: 17

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  23. 7 Dec 2022Insiders record

    Jones David B. (SVP, GC & CCO) bought 752 shares of IOSP ($81,208) (dated 6 Dec 2022)

  24. 7 Dec 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 7 Dec 2021Filings record

    Director or officer change

  26. 25 Feb 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 25 Feb 2021Filings record

    Director or officer change

  28. 6 Nov 2020Filings record

    Director or officer change

  29. 2 Nov 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 2 Nov 2020Filings record

    Director or officer change

  31. 11 Aug 2020Financials change

    reported revenue of $244.9M for the quarter ended 30 Jun 2020, 32% below the same quarter last year.

    Same quarter last year: $362.4M; its normal quarter is $372.1M.

    See the evidence
    This period
    $244.9M (the quarter ended 30 Jun 2020)
    Normal quarter (median of 8 earlier)
    $372.1M
    Typical spread (median absolute deviation)
    $11.8M
    How far from its usual level
    -3.4
    Same quarter last year
    $362.4M
    History used
    3,653 days
    2018-06-30: $358.1M2018-09-30: $363.1M2018-12-31: $395.0M2019-03-31: $388.3M2019-06-30: $362.4M2019-09-30: $371.9M2019-12-31: $390.7M2020-03-31: $372.3M2020-06-30: $244.9M
    the quarter ended 30 Jun 20208 earlier quartersnormal: $372.1M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 11 Mar 2020Short interest and volume change

    had 593K shares sold short in the 28 Feb 2020 report, 2.6× the same report last year.

    Same report last year: 228K; its normal report is 348K.

    See the evidence
    This period
    593K (the 28 Feb 2020 report)
    Normal report (median of 24 earlier)
    348K
    Typical spread (median absolute deviation)
    42K
    How far from its usual level
    +4.0
    Same report last year
    228K
    History used
    791 days
    2019-02-28: 228K2019-03-15: 281K2019-03-29: 281K2019-04-15: 287K2019-04-30: 302K2019-05-15: 263K2019-05-31: 396K2019-06-14: 375K2019-06-28: 360K2019-07-15: 382K2019-07-31: 375K2019-08-15: 311K2019-08-30: 361K2019-09-13: 381K2019-09-30: 342K2019-10-15: 333K2019-10-31: 392K2019-11-15: 305K2019-11-29: 268K2019-12-13: 355K2019-12-31: 367K2020-01-15: 392K2020-01-31: 388K2020-02-14: 289K2020-02-28: 593K
    the 28 Feb 2020 report24 earlier reportsnormal: 348K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 2 Mar 2020Filings record

    Director or officer change

  34. 20 Feb 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 20 Feb 2020Filings record

    Director or officer change

  36. 14 Aug 2019Institutional holdings change

    saw 29 13F filers open a new position in the quarter ended 30 Jun 2019, 1.3× the same quarter last year.

    Same quarter last year: 22; its normal quarter is 15.5.

    See the evidence
    This period
    29 (the quarter ended 30 Jun 2019)
    Normal quarter (median of 8 earlier)
    15.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +3.6
    Same quarter last year
    22
    History used
    2,099 days
    2017-06-30: 112017-09-30: 172017-12-31: 142018-03-31: 152018-06-30: 222018-09-30: 162018-12-31: 122019-03-31: 232019-06-30: 29
    the quarter ended 30 Jun 20198 earlier quartersnormal: 15.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  37. 3 Jun 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 3 Jun 2019Filings record

    Director or officer change

  39. 24 May 2019Filings record

    Changed its auditor

  40. 11 Apr 2019Filings record

    Changed its auditor

Showing the newest 40 of 46 entries; narrow the window or the kind of data to see older ones.

Not listed: 232 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001054905
Ticker
IOSP
Domain
innospec.com
Hq location
CO|ENGLEWOOD|80112 (1 unverified)
Name
Bachman Services, Inc. (USA) BioSuite LLC (USA), EX-21.1, Innospec Chemicals Beijing Limited, Innospec Chemicals (Shanghai) Limited and 10 more
Uei
QX9VDNJMPNN8
Wikipedia
Innospec
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)116 records17 Feb 2016 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1146 data points31 Dec 2008 to 31 Oct 2026
  • SEC Form 4 insider transactions145 records, 360 data points24 Feb 2016 to 12 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards12 data points29 Jul 2013 to 11 Aug 2014
  • Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026